Korneva V A, Kuznetsova T Yu, Murtazina R Z, Didio A V, Bogoslovskaya T Yu, Mandelshtam M Yu, Vasilyev V B
Petrozavodsk State University, Petrozavodsk, Russia.
Institute of Experimental Medicine, St. Petersburg, Russia.
Kardiologiia. 2017 Feb;57(2):12-16.
During investigation of molecular nature of familial hypercholesterolemia (FH) in Petrozavodsk (Russia) cohort of patients a novel low density lipoprotein (LDL) receptor gene mutation was found. This mutation designated c.1327 T>C (W443R [W422R]) was predicted to cause substitution of arginine for tryptophan residue in the very conservative -propeller domain of the LDL receptor. Inheritance of the new mutation was traced in four generations and its cosegregation with hypercholesterolemia phenotype was observed. Despite the predicted pathogenic effect of the mutation, ischemic heart disease in the pedigree was mild or absent. We consider identification of this mutation in the pedigree extremely helpful to start preventive medical treatment in affected patients.
在对俄罗斯彼得罗扎沃茨克家族性高胆固醇血症(FH)患者队列进行分子性质研究期间,发现了一种新的低密度脂蛋白(LDL)受体基因突变。该突变命名为c.1327 T>C(W443R [W422R]),预计会导致LDL受体非常保守的β-螺旋桨结构域中的色氨酸残基被精氨酸取代。新突变在四代中得以追踪,并观察到其与高胆固醇血症表型的共分离。尽管该突变具有预测的致病作用,但家系中的缺血性心脏病较轻或不存在。我们认为在该家系中鉴定出这种突变对开始对受影响患者进行预防性医学治疗极为有用。